{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T12:45:30Z","timestamp":1777293930061,"version":"3.51.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:00:00Z","timestamp":1769212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The 2024 Annual Plan for Medical Science Research Projects in Hebei Province","award":["20240585"],"award-info":[{"award-number":["20240585"]}]},{"name":"The 2024 Annual Plan for Medical Science Research Projects in Hebei Province","award":["20240585"],"award-info":[{"award-number":["20240585"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-35493-7","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T09:53:02Z","timestamp":1769248382000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["SHP2 promotes osteosarcoma via regulating STAT3\/TET3\/HOXB2 signaling"],"prefix":"10.1038","volume":"16","author":[{"given":"Hua","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangfeng","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,24]]},"reference":[{"issue":"10","key":"35493_CR1","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41571-021-00519-8","volume":"18","author":"J Gill","year":"2021","unstructured":"Gill, J. & Gorlick, R. Advancing therapy for osteosarcoma [J]. Nat. Rev. Clin. Oncol. 18 (10), 609\u2013624 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"35493_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2020.12.024","volume":"500","author":"C Chen","year":"2021","unstructured":"Chen, C. et al. Immunotherapy for osteosarcoma: fundamental mechanism, rationale, and recent breakthroughs [J]. Cancer Lett. 500, 1\u201310 (2021).","journal-title":"Cancer Lett."},{"key":"35493_CR3","doi-asserted-by":"crossref","unstructured":"Sheng, J. et al. circ-RANGAP1\/MicroRNA-542-3p\/Myosin Regulatory Light Chain Interacting Protein Axis Modulates the Osteosarcoma Cell Progression [J]. Appl Bionics Biomech, 2022, 4247670 (2022).","DOI":"10.1155\/2022\/4247670"},{"issue":"1","key":"35493_CR4","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1186\/s12885-023-11024-9","volume":"23","author":"C Zhang","year":"2023","unstructured":"Zhang, C. et al. Incidence, survival, and associated factors Estimation in osteosarcoma patients with lung metastasis: a single-center experience of 11 years in Tianjin, China [J]. BMC Cancer. 23 (1), 506 (2023).","journal-title":"BMC Cancer"},{"issue":"27","key":"35493_CR5","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1200\/JCO.2014.59.4895","volume":"33","author":"MS ISakoff","year":"2015","unstructured":"ISakoff, M. S. et al. Osteosarcoma: current treatment and a collaborative pathway to success [J]. J. Clin. Oncol. 33 (27), 3029\u20133035 (2015).","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"35493_CR6","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1111\/jcmm.12618","volume":"19","author":"J Zhang","year":"2015","unstructured":"Zhang, J., Zhang, F. & Niu, R. Functions of Shp2 in cancer [J]. J. Cell. Mol. Med. 19 (9), 2075\u20132083 (2015).","journal-title":"J. Cell. Mol. Med."},{"issue":"10","key":"35493_CR7","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/nrc909","volume":"2","author":"N Ferrara","year":"2002","unstructured":"Ferrara, N. VEGF and the quest for tumour angiogenesis factors [J]. Nat. Rev. Cancer. 2 (10), 795\u2013803 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"35493_CR8","doi-asserted-by":"crossref","unstructured":"Assi, T. et al. Targeting the VEGF pathway in osteosarcoma [J]. Cells, 10(5),1240 (2021).","DOI":"10.3390\/cells10051240"},{"issue":"5","key":"35493_CR9","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nrd.2018.21","volume":"17","author":"FM Ferguson","year":"2018","unstructured":"Ferguson, F. M. & Gray, N. S. Kinase inhibitors: the road ahead [J]. Nat. Rev. Drug Discov. 17 (5), 353\u2013377 (2018).","journal-title":"Nat. Rev. Drug Discov"},{"issue":"1","key":"35493_CR10","doi-asserted-by":"publisher","first-page":"6310","DOI":"10.1038\/s41467-021-26697-8","volume":"12","author":"Z Xu","year":"2021","unstructured":"Xu, Z. et al. Endothelial deletion of SHP2 suppresses tumor angiogenesis and promotes vascular normalization [J]. Nat. Commun. 12 (1), 6310 (2021).","journal-title":"Nat. Commun."},{"issue":"49","key":"35493_CR11","doi-asserted-by":"publisher","first-page":"7166","DOI":"10.1038\/s41388-020-01488-5","volume":"39","author":"H Chen","year":"2020","unstructured":"Chen, H. et al. SHP2 is a multifunctional therapeutic target in drug resistant metastatic breast cancer [J]. Oncogene 39 (49), 7166\u20137180 (2020).","journal-title":"Oncogene"},{"issue":"1","key":"35493_CR12","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13058-015-0659-z","volume":"18","author":"F Matalkah","year":"2016","unstructured":"Matalkah, F. et al. SHP2 acts both upstream and downstream of multiple receptor tyrosine kinases to promote basal-like and triple-negative breast cancer [J]. Breast Cancer Res. 18 (1), 2 (2016).","journal-title":"Breast Cancer Res."},{"key":"35493_CR13","doi-asserted-by":"crossref","unstructured":"Nagamura, Y. et al. SHP2 as a potential therapeutic target in Diffuse-Type gastric carcinoma addicted to receptor tyrosine kinase signaling [J]. Cancers (Basel), 13(17),4309 (2021).","DOI":"10.3390\/cancers13174309"},{"issue":"12","key":"35493_CR14","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/nrd.2018.201","volume":"17","author":"A Mullard","year":"2018","unstructured":"Mullard, A. Phosphatases start shedding their stigma of undruggability [J]. Nat. Rev. Drug Discov. 17 (12), 847\u2013849 (2018).","journal-title":"Nat. Rev. Drug Discov"},{"issue":"5","key":"35493_CR15","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1038\/s41375-018-0020-5","volume":"32","author":"X Sun","year":"2018","unstructured":"Sun, X. et al. Selective Inhibition of leukemia-associated SHP2(E69K) mutant by the allosteric SHP2 inhibitor SHP099 [J]. Leukemia 32 (5), 1246\u20131249 (2018).","journal-title":"Leukemia"},{"issue":"12","key":"35493_CR16","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1016\/j.celrep.2015.08.037","volume":"12","author":"A Prahallad","year":"2015","unstructured":"Prahallad, A. et al. PTPN11 is a central node in intrinsic and acquired resistance to targeted cancer drugs [J]. Cell. Rep. 12 (12), 1978\u20131985 (2015).","journal-title":"Cell. Rep."},{"issue":"8","key":"35493_CR17","doi-asserted-by":"publisher","first-page":"6191","DOI":"10.18632\/oncotarget.3356","volume":"6","author":"VE Schneeberger","year":"2015","unstructured":"Schneeberger, V. E. et al. Inhibition of Shp2 suppresses mutant EGFR-induced lung tumors in Transgenic mouse model of lung adenocarcinoma [J]. Oncotarget 6 (8), 6191\u20136202 (2015).","journal-title":"Oncotarget"},{"issue":"1","key":"35493_CR18","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12943-020-01258-7","volume":"19","author":"S Zou","year":"2020","unstructured":"Zou, S. et al. Targeting STAT3 in cancer immunotherapy [J]. Mol. Cancer. 19 (1), 145 (2020).","journal-title":"Mol. Cancer"},{"issue":"6","key":"35493_CR19","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1038\/s41418-019-0460-0","volume":"27","author":"C Liu","year":"2020","unstructured":"Liu, C. et al. Macrophage-derived CCL5 facilitates immune escape of colorectal cancer cells via the p65\/STAT3-CSN5-PD-L1 pathway [J]. Cell. Death Differ. 27 (6), 1765\u20131781 (2020).","journal-title":"Cell. Death Differ."},{"key":"35493_CR20","doi-asserted-by":"publisher","first-page":"102956","DOI":"10.1016\/j.redox.2023.102956","volume":"68","author":"L Meng","year":"2023","unstructured":"Meng, L. et al. MIOX inhibits autophagy to regulate the ROS -driven Inhibition of STAT3\/c-Myc-mediated epithelial-mesenchymal transition in clear cell renal cell carcinoma [J]. Redox Biol. 68, 102956 (2023).","journal-title":"Redox Biol."},{"issue":"5","key":"35493_CR21","doi-asserted-by":"publisher","first-page":"e13863","DOI":"10.1111\/aji.13863","volume":"91","author":"J Ma","year":"2024","unstructured":"Ma, J. et al. NANOG regulate the JAK\/STAT3 pathway to promote trophoblast cell migration and epithelial-mesenchymal transition (EMT) in hypertensive disorders of pregnancy (HDP) through protein interaction with CDK1 [J]. Am. J. Reprod. Immunol. 91 (5), e13863 (2024).","journal-title":"Am. J. Reprod. Immunol."},{"key":"35493_CR22","doi-asserted-by":"crossref","unstructured":"Chi, J. et al. TET3 Mediates 5hmC Level and Promotes Tumorigenesis by Activating AMPK Pathway in Papillary Thyroid Cancer [J]. Int J Endocrinol, 2022, 2658727 (2022).","DOI":"10.1155\/2022\/2658727"},{"key":"35493_CR23","doi-asserted-by":"publisher","first-page":"216285","DOI":"10.1016\/j.canlet.2023.216285","volume":"567","author":"M Chen","year":"2023","unstructured":"Chen, M. et al. NUSAP1-LDHA-Glycolysis-Lactate feedforward loop promotes Warburg effect and metastasis in pancreatic ductal adenocarcinoma [J]. Cancer Lett. 567, 216285 (2023).","journal-title":"Cancer Lett."},{"issue":"3","key":"35493_CR24","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1177\/03009858221083038","volume":"59","author":"J Beck","year":"2022","unstructured":"Beck, J. et al. Canine and murine models of osteosarcoma [J]. Vet. Pathol. 59 (3), 399\u2013414 (2022).","journal-title":"Vet. Pathol."},{"issue":"12","key":"35493_CR25","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1158\/1078-0432.CCR-21-4509","volume":"28","author":"A Takemoto","year":"2022","unstructured":"Takemoto, A. et al. Targeting Podoplanin for the treatment of osteosarcoma [J]. Clin. Cancer Res. 28 (12), 2633\u20132645 (2022).","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"35493_CR26","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1111\/cas.15739","volume":"114","author":"G He","year":"2023","unstructured":"He, G. et al. Formin-like 2 promotes angiogenesis and metastasis of colorectal cancer by regulating the EGFL6\/CKAP4\/ERK axis [J]. Cancer Sci. 114 (5), 2014\u20132028 (2023).","journal-title":"Cancer Sci."},{"key":"35493_CR27","doi-asserted-by":"crossref","unstructured":"Lambert, L. J. et al. Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors [J]. J Vis Exp (161), (2020).","DOI":"10.3791\/61457"},{"issue":"5","key":"35493_CR28","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1002\/cmdc.201500015","volume":"10","author":"S Grosskopf","year":"2015","unstructured":"Grosskopf, S. et al. Selective inhibitors of the protein tyrosine phosphatase SHP2 block cellular motility and growth of cancer cells in\u2005vitro and in\u2005vivo [J]. ChemMedChem 10 (5), 815\u2013826 (2015).","journal-title":"ChemMedChem"},{"issue":"4","key":"35493_CR29","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","volume":"15","author":"DE Johnson","year":"2018","unstructured":"Johnson, D. E., O\u2019Keefe, R. A. & Grandis, J. R. Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer [J]. Nat. Rev. Clin. Oncol. 15 (4), 234\u2013248 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"35493_CR30","doi-asserted-by":"publisher","first-page":"1023177","DOI":"10.3389\/fonc.2022.1023177","volume":"12","author":"B Huang","year":"2022","unstructured":"Huang, B., Lang, X. & Li, X. The role of IL-6\/JAK2\/STAT3 signaling pathway in cancers [J]. Front. Oncol. 12, 1023177 (2022).","journal-title":"Front. Oncol."},{"key":"35493_CR31","doi-asserted-by":"publisher","first-page":"944455","DOI":"10.3389\/fphar.2022.944455","volume":"13","author":"H Li","year":"2022","unstructured":"Li, H. et al. Design, synthesis, and biological characterization of a potent STAT3 degrader for the treatment of gastric cancer [J]. Front. Pharmacol. 13, 944455 (2022).","journal-title":"Front. Pharmacol."},{"key":"35493_CR32","doi-asserted-by":"crossref","unstructured":"To, S. Q. et al. STAT3 signaling in breast cancer: multicellular actions and therapeutic potential [J]. Cancers (Basel), 14(2),429 (2022).","DOI":"10.3390\/cancers14020429"},{"key":"35493_CR33","doi-asserted-by":"crossref","unstructured":"Mohrherr, J. et al. STAT3: versatile functions in Non-Small cell lung cancer [J]. Cancers (Basel), 12(5),1107 (2020).","DOI":"10.3390\/cancers12051107"},{"issue":"7310","key":"35493_CR34","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/nature09303","volume":"466","author":"S Ito","year":"2010","unstructured":"Ito, S. et al. Role of tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification [J]. Nature 466 (7310), 1129\u20131133 (2010).","journal-title":"Nature"},{"issue":"6047","key":"35493_CR35","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1126\/science.1210597","volume":"333","author":"S Ito","year":"2011","unstructured":"Ito, S. et al. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine [J]. Science 333 (6047), 1300\u20131303 (2011).","journal-title":"Science"},{"issue":"24","key":"35493_CR36","doi-asserted-by":"publisher","first-page":"10385","DOI":"10.1093\/nar\/17.24.10385","volume":"17","author":"D Acampora","year":"1989","unstructured":"Acampora, D. et al. The human HOX gene family [J]. Nucleic Acids Res. 17 (24), 10385\u201310402 (1989).","journal-title":"Nucleic Acids Res."},{"key":"35493_CR37","doi-asserted-by":"publisher","first-page":"10107","DOI":"10.2147\/OTT.S230098","volume":"12","author":"B Pan","year":"2019","unstructured":"Pan, B. et al. LncRNA RGMB-AS1 promotes glioma growth and invasion through miR-1200\/HOXB2 axis [J]. Onco Targets Ther. 12, 10107\u201310114 (2019).","journal-title":"Onco Targets Ther."},{"issue":"2","key":"35493_CR38","doi-asserted-by":"publisher","first-page":"188358","DOI":"10.1016\/j.bbcan.2020.188358","volume":"1873","author":"SA De Bessa Garcia","year":"2020","unstructured":"De Bessa Garcia, S. A. et al. HOX genes function in breast cancer development [J]. Biochim. Biophys. Acta Rev. Cancer. 1873 (2), 188358 (2020).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"11","key":"35493_CR39","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1080\/15384101.2019.1618127","volume":"18","author":"S Li","year":"2019","unstructured":"Li, S. et al. Circular RNA 0001785 regulates the pathogenesis of osteosarcoma as a CeRNA by sponging miR-1200 to upregulate HOXB2 [J]. Cell. Cycle. 18 (11), 1281\u20131291 (2019).","journal-title":"Cell. Cycle"},{"key":"35493_CR40","doi-asserted-by":"crossref","unstructured":"Luo, B. et al. Transcription factor HOXB2 upregulates NUSAP1 to promote the proliferation, invasion and migration of nephroblastoma cells via the PI3K\/Akt signaling pathway [J]. Mol. Med. Rep., 25(6),205 (2022).","DOI":"10.3892\/mmr.2022.12721"},{"key":"35493_CR41","doi-asserted-by":"crossref","unstructured":"Carabet, L. A., Rennie, P. S. & Cherkasov, A. Therapeutic Inhibition of Myc in Cancer. Structural bases and Computer-Aided drug discovery approaches [J]. Int. J. Mol. Sci., 20(1),120 (2018).","DOI":"10.3390\/ijms20010120"},{"issue":"1","key":"35493_CR42","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s40659-021-00363-1","volume":"54","author":"R Ning","year":"2021","unstructured":"Ning, R. et al. Diosmetin inhibits cell proliferation and promotes apoptosis through STAT3\/c-Myc signaling pathway in human osteosarcoma cells [J]. Biol. Res. 54 (1), 40 (2021).","journal-title":"Biol. Res."},{"issue":"7","key":"35493_CR43","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1080\/15384047.2017.1416273","volume":"19","author":"S Li","year":"2018","unstructured":"Li, S. et al. Nucleoside diphosphate kinase B promotes osteosarcoma proliferation through c-Myc [J]. Cancer Biol. Ther. 19 (7), 565\u2013572 (2018).","journal-title":"Cancer Biol. Ther."},{"issue":"1","key":"35493_CR44","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12967-023-03985-z","volume":"21","author":"G Sheng","year":"2023","unstructured":"Sheng, G. et al. P2RX7 promotes osteosarcoma progression and glucose metabolism by enhancing c-Myc stabilization [J]. J. Transl Med. 21 (1), 132 (2023).","journal-title":"J. Transl Med."},{"issue":"Suppl 4(3","key":"35493_CR45","first-page":"22","volume":"26","author":"RHH Ching","year":"2020","unstructured":"Ching, R. H. H. et al. C-terminal truncated hepatitis B virus X protein regulates tumourigenicity, self-renewal, and chemoresistance via STAT3\/Nanog signalling pathway: abridged secondary publication [J]. Hong Kong Med. J. 26 (Suppl 4(3), 22\u201325 (2020).","journal-title":"Hong Kong Med. J."},{"issue":"26","key":"35493_CR46","doi-asserted-by":"publisher","first-page":"6511","DOI":"10.7150\/jca.29931","volume":"10","author":"C zhang","year":"2019","unstructured":"zhang, C., Ma, K. & Li, W. Y. IL-6 promotes cancer stemness and oncogenicity in U2OS and MG-63 osteosarcoma cells by upregulating the OPN-STAT3 pathway [J]. J. Cancer. 10 (26), 6511\u20136525 (2019).","journal-title":"J. Cancer"},{"issue":"Pt 19","key":"35493_CR47","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.1242\/jcs.063875","volume":"123","author":"A Vanden Bosch","year":"2010","unstructured":"Vanden Bosch, A. et al. NuSAP is essential for chromatin-induced spindle formation during early embryogenesis [J]. J. Cell. Sci. 123 (Pt 19), 3244\u20133255 (2010).","journal-title":"J. Cell. Sci."},{"issue":"6","key":"35493_CR48","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.cellsig.2010.11.006","volume":"23","author":"J Iyer","year":"2011","unstructured":"Iyer, J. et al. What\u2019s Nu(SAP) in mitosis and cancer? [J]. Cell. Signal. 23 (6), 991\u2013998 (2011).","journal-title":"Cell. Signal."},{"issue":"1","key":"35493_CR49","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1515\/med-2020-0180","volume":"16","author":"L Zhang","year":"2021","unstructured":"Zhang, L. et al. Hypoxia stimulates the migration and invasion of osteosarcoma via up-regulating the NUSAP1 expression [J]. Open. Med. (Wars). 16 (1), 1083\u20131089 (2021).","journal-title":"Open. Med. (Wars)"},{"key":"35493_CR50","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.2147\/OTT.S295818","volume":"14","author":"H Wang","year":"2021","unstructured":"Wang, H. et al. NUSAP1 accelerates osteosarcoma cell proliferation and cell cycle progression via upregulating CDC20 and Cyclin A2 [J]. Onco Targets Ther. 14, 3443\u20133454 (2021).","journal-title":"Onco Targets Ther."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35493-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35493-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35493-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T11:03:46Z","timestamp":1770980626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35493-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,24]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["35493"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-35493-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,24]]},"assertion":[{"value":"2 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study has been approved by the Medical Ethics Committee of Xingtai general Hospital.(Approval number:2023023).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"6158"}}